Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2019 How Should Physicians Help Patients Understand Unknowns of Nanoparticle-Based Medicines? Nancy M. P. King, JD and Christine E. Bishop, MD, MA When an unproven intervention is a nanodrug, a physician’s role is especially difficult due to possibilities of unprecedented harms. AMA J Ethics. 2019;21(4):E324-331. doi: 10.1001/amajethics.2019.324. Viewpoint Sep 2016 The Limits of Informed Consent for an Overwhelmed Patient: Clinicians’ Role in Protecting Patients and Preventing Overwhelm Johan Bester, MBChB, MPhil, Cristie M. Cole, JD, and Eric Kodish, MD Protecting patients rather than informed consent should be the goal when the complexity of information overwhelms patients’ decision-making capacity. AMA J Ethics. 2016;18(9):869-886. doi: 10.1001/journalofethics.2016.18.9.peer2-1609. Podcast Aug 2016 Ethics Talk: Clinical and Research Ethics in Pathology - An Interview with Theonia Boyd This month, AMA Journal of Ethics theme editor Margaret Cocks, MD, PhD, a third-year resident at Johns Hopkins Hospital, interviewed Theonia Boyd, MD, about ethical issues pathologists face when conducting autopsies and obtaining specimens. Case and Commentary Dec 2016 Neuroethics and Disorders of Consciousness: Discerning Brain States in Clinical Practice and Research Joseph J. Fins, MD Which distinctions between minimally conscious states and vegetative states should clinicians consider? AMA J Ethics. 2016;18(12):1182-1191. doi: 10.1001/journalofethics.2016.18.12.ecas2-1612. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Who Is That? Expanding the Clinical Encounter Vijaya Arekapudi, MD Virtual Mentor. 2004;6(11):486-487. doi: 10.1001/virtualmentor.2004.6.11.ccas3-0411. Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Case and Commentary Apr 2019 How Should Physicians Help Patients Understand Unknowns of Nanoparticle-Based Medicines? Nancy M. P. King, JD and Christine E. Bishop, MD, MA When an unproven intervention is a nanodrug, a physician’s role is especially difficult due to possibilities of unprecedented harms. AMA J Ethics. 2019;21(4):E324-331. doi: 10.1001/amajethics.2019.324.
Viewpoint Sep 2016 The Limits of Informed Consent for an Overwhelmed Patient: Clinicians’ Role in Protecting Patients and Preventing Overwhelm Johan Bester, MBChB, MPhil, Cristie M. Cole, JD, and Eric Kodish, MD Protecting patients rather than informed consent should be the goal when the complexity of information overwhelms patients’ decision-making capacity. AMA J Ethics. 2016;18(9):869-886. doi: 10.1001/journalofethics.2016.18.9.peer2-1609.
Podcast Aug 2016 Ethics Talk: Clinical and Research Ethics in Pathology - An Interview with Theonia Boyd This month, AMA Journal of Ethics theme editor Margaret Cocks, MD, PhD, a third-year resident at Johns Hopkins Hospital, interviewed Theonia Boyd, MD, about ethical issues pathologists face when conducting autopsies and obtaining specimens.
Case and Commentary Dec 2016 Neuroethics and Disorders of Consciousness: Discerning Brain States in Clinical Practice and Research Joseph J. Fins, MD Which distinctions between minimally conscious states and vegetative states should clinicians consider? AMA J Ethics. 2016;18(12):1182-1191. doi: 10.1001/journalofethics.2016.18.12.ecas2-1612.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Who Is That? Expanding the Clinical Encounter Vijaya Arekapudi, MD Virtual Mentor. 2004;6(11):486-487. doi: 10.1001/virtualmentor.2004.6.11.ccas3-0411.
Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411.